Clinical Trial Update: Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating oral ixazomib in combination with melphalan and prednisone for newly diagnosed multiple myeloma has completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ixazomib (ixazomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-01-23